Will LLY's Oncology Portfolio Provide Key Diversification Benefits?Zacks Investment Research • 09/09/25
Lilly launches new "Brain Health Matters" campaign in partnership with Julianne Moore, empowering the public to prioritize brain healthPRNewsWire • 09/09/25
Circle Pharma Announces Agreement with Lilly to Further Enhance AI/ML Capabilities and Accelerate Development of New Oral Macrocycle TherapiesBusiness Wire • 09/09/25
Lilly launches TuneLab platform to give biotechnology companies access to AI-enabled drug discovery models built through over $1 billion in research investmentPRNewsWire • 09/09/25
Eli Lilly And Company (LLY) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/08/25
Lilly's Jaypirca (pirtobrutinib), the first and only approved non-covalent (reversible) BTK inhibitor, significantly improved progression-free survival in patients with treatment-naïve CLL/SLLPRNewsWire • 09/08/25
Eli Lilly And Company (LLY) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)Seeking Alpha • 09/05/25
2 S&P 500 Dividend Stocks That Could Climb More Than 20% According to Wall Street AnalystsThe Motley Fool • 09/05/25
Lila Biologics Announces Collaboration with Lilly For Radioligand Therapy Discovery and DevelopmentGlobeNewsWire • 09/04/25
Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of certain newly diagnosed metastatic KRAS G12C-mutant lung cancersPRNewsWire • 09/04/25